Skip to content
Home/Companies/Biotech/21st.BIO

21st.BIO

Biotech·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns 21st.BIO?

21st.BIO is a Danish Biotech company, currently owned by Novo Holdings since 2021.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Bioindustrial Investments · 1999 · Buyout

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Novo Holdings Bioindustrial Investments

Other portfolio companies in the same fund.

Elo Life Systems
Active
AgTechUS· 2022
AMSilk
Active
BiotechGermany· 2021
Bactolife
Active
BiotechDenmark· 2021
Esco Aster
Active
FoodTechSingapore· 2021
Geno
Active
BiotechUS· 2021
Zencore Biologics
Active
BiotechUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns 21st.BIO?

21st.BIO is currently owned by Novo Holdings, through Novo Holdings Bioindustrial Investments, since 2021.

When did Novo Holdings acquire 21st.BIO?

Novo Holdings acquired 21st.BIO in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue